Home/Pipeline/PNT2003

PNT2003

Neuroendocrine Tumors (Therapeutic)

Phase 3Acquired Program

Key Facts

Indication
Neuroendocrine Tumors (Therapeutic)
Phase
Phase 3
Status
Acquired Program
Company

About Lantheus Medical Imaging

Lantheus Medical Imaging is a leading public radiopharmaceutical company with a mission to 'Find, Fight, and Follow' disease through targeted diagnostic and therapeutic innovations. The company has achieved significant commercial success with products like PYLARIFY for prostate cancer imaging and is aggressively expanding its pipeline through strategic acquisitions and internal R&D into high-growth areas like radiotherapeutics and neurology diagnostics. Its strategy hinges on vertical integration, managing complex radiopharmaceutical logistics, and capitalizing on the growing precision medicine paradigm in nuclear medicine.

View full company profile